(Q35179541)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

title

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

13

Claudio Viscoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

7

Peter M Hawkey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Jane P Barrett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Katerina A Vardulaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Christopher Conlon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jonathan Cooke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Pascual Daza-Ramirez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Glyn V Evans

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

David I Marks

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jose M Moraleda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Gilbert R Park

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Stephen J Senn

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Amphotericin B Systematic Review Study Group

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1295-1320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Lipid-based amphotericin B: a review of the last 10 years of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Management of fungal infections in neutropenic patients: more doubts than certainties?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Renal effects of amphotericin B lipid complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Use of amphotericin B colloidal dispersion in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Correlates of acute renal failure in patients receiving parenteral amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Risk factors for Amphotericin B-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Risk factors for amphotericin B-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

Pulmonary extraction and accumulation of lipid formulations of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980125-X

7 January 2021

10.1016/S0149-2918(03)80125-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12867214%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference